Skip to main content
. 2020 Jan 9;21(2):423. doi: 10.3390/ijms21020423

Figure 1.

Figure 1

Crocetin (CCT) reduces proliferation and induces morphology changes in glioma cells. (A) Cell counts in U251, U87MG, U373, and U138 glioblastoma (GBM) cell lines performed at 72 h of treatment with 250 and 500 μM of crocetin. (B) Representative images of GBM cell lines in culture acquired at 40× magnification (bar corresponds to 100 μm).